Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Capecitabine MeSH Descriptor Data 2026


MeSH Heading
Capecitabine
Tree Number(s)
D03.383.742.680.245.500.425
D03.383.742.698.875.404.425
D13.570.230.329.313
D13.570.685.245.500.425
Unique ID
D000069287
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D000069287
Scope Note
A deoxycytidine derivative and fluorouracil PRODRUG that is used as an ANTINEOPLASTIC ANTIMETABOLITE in the treatment of COLON CANCER; BREAST CANCER and GASTRIC CANCER.
Entry Term(s)
N(4)-pentyloxycarbonyl-5'-deoxy-5-fluorocytidine
Xeloda
Pharm Action
Antimetabolites, Antineoplastic
Registry Numbers
6804DJ8Z9U
0
Related Numbers
154361-50-9
Public MeSH Note
2016; CAPECITABINE was indexed under DEOXYCYTIDINE and FLUOROURACIL 1998-2015
History Note
2016 (1998)
Date Introduced
2016/01/01
Last Updated
2016/05/27
Capecitabine Preferred
Xeloda Narrower
page delivered in 0.149s